<scp>EPID</scp>‐based <i>in vivo</i> dosimetry using Dosimetry Check™: Overview and clinical experience in a 5‐yr study including breast, lung, prostate, and head and neck cancer patients

Abstract

This preliminary data shows that EPID-based IVD with DC may not only be useful in detecting errors but has the potential to be used to establish site-specific dose action levels. The approach is straightforward and has been implemented as a radiographer-led service with no disruption to the patient and no impact on treatment time.